Suppression of inflammatory response and endothelial nitric oxide synthase downregulation in hyperlipidaemic C57BL/6J mice by eugenosedin-A

Journal of Pharmacy and Pharmacology

Volumn 63, Issue 6, 2011, Pages 860-868

  Shen, Kuo Ping ^a   Lin, Hui Li ^a   Chang, Wen Tsan ^b   An, Li Mei ^c   Chen, Ing Jun ^c   Wu, Bin Nan ^c  

^a MEIHO UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

atorvastatin; eNOS; eugenosedin A; hyperlipidaemia; inflammation

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTILIPEMIC AGENT; APOPTOSIS SIGNAL REGULATING KINASE 1; ATORVASTATIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; EUGENOSEDIN A; GAMMA INTERFERON; I KAPPA B KINASE ALPHA; INDUCIBLE NITRIC OXIDE SYNTHASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; MITOGEN ACTIVATED PROTEIN KINASE KINASE 6; MITOGEN ACTIVATED PROTEIN KINASE KINASE 7; PROSTAGLANDIN E2; PROTEIN KINASE B; RAC PROTEIN; STEROID RECEPTOR COACTIVATOR 1; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; SYNAPTOTAGMIN I; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; AORTA; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; ENZYME BLOOD LEVEL; ENZYME INHIBITION; FEMALE; HYPERLIPIDEMIA; INFLAMMATION; LIPID DIET; LIVER; MOUSE; NONHUMAN; PROSTAGLANDIN BLOOD LEVEL; PROTEIN EXPRESSION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; AORTA; DIETARY FATS; DOWN-REGULATION; ENDOTHELIUM, VASCULAR; FEMALE; HEPTANOIC ACIDS; HYPERLIPIDEMIAS; INFLAMMATION; INTERFERON-GAMMA; LIVER; MICE; MICE, INBRED C57BL; MITOGEN-ACTIVATED PROTEIN KINASES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; OBESITY; PIPERAZINES; PYRROLES; RANDOM ALLOCATION; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79956226392     PISSN: 00223573     EISSN: 20427158     Source Type: Journal    
DOI: 10.1111/j.2042-7158.2011.01285.x     Document Type: Article

References (26)

1. Riad A, et al,. Low-dose treatment with atorvastatin leads to anti-oxidative and anti-inflammatory effects in diabetes mellitus. Eur J Pharmacol 2007; 569: 204-211. (Pubitemid 47202015)
2. Stocker R, Keaney JF Jr,. Role of oxidative modifications in atherosclerosis. Physiol Rev 2004; 84: 1381-1478. (Pubitemid 39302636)
3. Prasad K,. Hypocholesterolemic and antiatherosclerotic effect of flax lignan complex isolated from flaxseed. Atherosclerosis 2005; 179: 269-275. (Pubitemid 40364620)
4. Prasad K,. Dietary flaxseed in prevention of hypercholesterolemic atherosclerosis. Atherosclerosis 1997; 132: 69-76. (Pubitemid 27306741)
5. Prasad K, Lee P,. Suppression of hypercholesterolemic atherosclerosis by pentoxifylline and its mechanism. Atherosclerosis 2007; 192: 313-322. (Pubitemid 46726333)
6. Behr-Roussel D, et al,. Effect of chronic treatment with the inducible nitric oxide synthase inhibitor N-iminoethyl-L-lysine or with L-arginine on progression of coronary and aortic atherosclerosis in hypercholesterolemic rabbits. Circulation 2000; 102: 1033-1038. (Pubitemid 30656011)
7. Park JH, Levitt L,. Overexpression of mitogen-activated protein kinase (ERK1) enhances T-cell cytokine gene expression: role of AP-1, NF-AT, and NF-κB. Blood 1993; 82: 2470-2477. (Pubitemid 23304271)
8. Kushiyama A, et al,. Resistin-like molecule beta activates MAPKs, suppresses insulin signaling in hepatocytes, and induces diabetes, hyperlipidemia, and fatty liver in transgenic mice on a high fat diet. J Biol Chem 2005; 280: 42016-42025. (Pubitemid 43023170)
9. Ting HJ, et al,. Triglyceride-rich lipoproteins prime aortic endothelium for an enhanced inflammatory response to tumor necrosis factor-alpha. Circ Res 2007; 100: 381-390.
10. Osto E, et al,. c-Jun N-terminal kinase 2 deficiency protects against hypercholesterolemia-induced endothelial dysfunction and oxidative stress. Circulation 2008; 118: 2073-2080.
11. Molnar J, et al,. Diabetes induces endothelial dysfunction but does not increase neointimal formation in high-fat diet fed C57BL/6J mice. Circ Res 2005; 96: 1178-1184. (Pubitemid 40827693)
12. Wang Q, et al,. Neutrophils in innate immunity. Semin Respir Crit Care Med 2004; 25: 33-41. (Pubitemid 38296157)
13. Ellis TN, Beaman BL,. Interferon-γ activation of polymorphonuclear neutrophil function. Immunology 2004; 112: 2-12. (Pubitemid 38609816)
14. Galili O, et al,. Early experimental obesity is associated with coronary endothelial dysfunction and oxidative stress. Am J Physiol Heart Circ Physiol 2007; 292: H904-H911.
15. Shen KP, et al,. Hypotensive effects of eugenosedin-A with serotonin, α- and β-adrenoceptor antagonistic activities in spontaneously hypertensive and normotensive rats. Pharmacology 2004; 71: 91-101.
16. Shen KP, et al,. Eugenosedin-A amelioration of lipopolysaccharide-induced up-regulation of p38 MAPK, inducible nitric oxide synthase and cyclooxygenase-2. J Pharm Pharmacol 2007; 59: 879-889.
17. Shen KP, et al,. Eugenosedin-A prevention of hyperglycaemia, hyperlipidaemia and lipid peroxidation in C57BL/6J mice fed with high-fat diet. J Pharm Pharmacol 2009; 61: 517-525.
18. Wu BN, et al,. Inhibition of pro-inflammatory TNF-α-induced iNOS by xanthine-based KMUP-1 and KMUP-3 in rat trachea: the involvement of soluble guanylate cyclase and protein kinase G. Mol Pharmacol 2006; 70: 977-985.
19. Steinberg D,. Hypercholesterolemia and inflammation in atherogenesis: two sides of the same coin. Mol Nutr Food Res 2005; 49: 995-998. (Pubitemid 41735560)
20. Perreault M, Marette A,. Targeted disruption of inducible nitric oxide synthase protects against obesity-linked insulin resistance in muscle. Nat Med 2001; 7: 1138-1143. (Pubitemid 33010023)
21. Rein D, et al,. Transgenic flavonoid tomato intake reduces C-reactive protein in human C-reactive protein transgenic mice more than wild-type tomato. J Nutr 2006; 136: 2331-2337. (Pubitemid 44329991)
22. Weisberg SP, et al,. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003; 112: 1796-1808. (Pubitemid 38063703)
23. Bowie A, O'Neill LA,. Oxidative stress and nuclear factor-kappaB activation: a reassessment of the evidence in the light of recent discoveries. Biochem Pharmacol 2000; 59: 13-23.
24. Kyriakis JM, Avruch J,. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev 2001; 81: 807-869. (Pubitemid 32267078)
25. Stokes KY, et al,. Role of interferon-gamma in hypercholesterolemia- induced leukocyte-endothelial cell adhesion. Circulation 2003; 107: 2140-2145. (Pubitemid 36532197)
26. Kawashima S, Yokoyama M,. Dysfunction of endothelial nitric oxide synthase and atherosclerosis. Arterioscler Thromb Vasc Biol 2004; 24: 998-1005. (Pubitemid 38737823)